Reporting owner · CIK 0001363558

Collard Craig A

SEC Form 4 history for the last 180 days across 1 company, 9 transactions and 2 filings.

CEOChief Executive OfficerHERON THERAPEUTICS, INC. DE
Open-market transaction mix—0 buys · 0 sales

Period: Last 180 days

Trade dates in this period: Oct 19, 2026 – Oct 31, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings2Form 4 records
Buying$00 purchases
Selling$00 sales
Net value$0Buys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Collard Craig A transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
SEC filing ↗
−$2.37kView disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
—View disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
SEC filing ↗
−$3.41kView disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
—View disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
SEC filing ↗
−$1.21kView disclosure →
HRTXHERON THERAPEUTICS, INC. DE
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
—View disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

No latest transaction fact is available.

Latest buy

No open-market insider purchase is available.

Latest sale

No open-market insider sale is available.

Monthly open-market activity

Last 1 reported month · purchases and sales

No open-market purchases or sales in this history.

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Oct 202600$0$0$0

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size—
Median P/S size—
Direct9
Indirect0
Oct 31, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

6 observations · Oct 19, 2026 – Oct 31, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 31, 2026931,086 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Oct 19, 2026870,289Oct 21, 2026View transaction
Oct 19, 2026866,929Oct 21, 2026View transaction
Oct 30, 2026916,950Nov 3, 2026View transaction
Oct 30, 2026904,769Nov 3, 2026View transaction
Oct 31, 2026939,557Nov 3, 2026View transaction
Oct 31, 2026931,086Nov 3, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Collard Craig A Insider Activity FAQ

SEC Form 4 context

Who is Collard Craig A?

Collard Craig A is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001363558.

Which companies has Collard Craig A reported transactions for?

HERON THERAPEUTICS, INC. DE, TerrAscend Corp.

When was Collard Craig A's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Collard Craig A's latest insider sale?

No open-market insider sale is recorded in the last 180 days. Earlier filings are outside the visible history.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.